Introduction
Transmissible spongiform encephalopathies (TSEs) and Alzheimer's disease (AD) share certain neuropathological and molecular features (Aguzzi and Haass, 2003; Checler and Vincent, 2002; DeArmond, 1993; Ironside and Head, 2008; Price et al., 1993) . In TSEs, such as bovine spongiform encephalopathy (BSE), or Creutzfeldt-Jakob disease (CJD) in humans, the cellular prion protein (PrP  c ) is abnormally converted to a protease-resistant form termed PrP sc (Prusiner, 1991; Prusiner, 1998) . In Alzheimer's disease, sequential proteolytic cleavage by β-(generating βCTF fragment) and γ-secretases of the amyloid precursor protein (APP) leads to an extracellular overproduction of β-amyloid (Aβ) peptides. They consist of 40-42 amino acids and comprise the senile plaques characteristic of such proteinopathies (Mattson, 2004; Selkoe, 2001 ). Deposition of both PrP sc and Aβ in the central nervous system (CNS) results in neurodegeneration. Moreover, the coexistence of Aβ and PrP sc amyloid deposits in affected brains, although controversial, has been widely reported (Barcikowska et al., 1995; Debatin et al., 2008; Ferrer et al., 2001; Hainfellner et al., 1998; Leuba et al., 2000; Tsuchiya et al., 2004) . In addition, a recent study indicates that PrP c may participate in the removal of Aβ oligomers, which would implicate PrP c in AD (Charveriat et al., 2009) . CJD is the most common human prion disease; it is classified as sporadic (sCJD), familial (fCJD), iatrogenic (iCJD) and variant (vCJD) (Glatzel et al., 2003) . Although sCJD is rare, with an incidence of 0.6-1.2 per million, it accounts for about 85% of all recognized human cases of prion disease (Brandel et al., 2000; Hill et al., 2003) . Two predominant PrP sc types have been identified, based on the gel mobility of the PrP sc fragments resistant to proteinase K (PK) treatment, and they are associated with different CJD phenotypes (Cali et al., 2006; Gambetti et al., 2003; Monari et al., 1994; Petersen et al., 1994) . Parallel to this, PRNP polymorphism at codon 129 (Met 129 →Val) modulates sensitivity to CJD, and methionine homozygosis is a risk factor for sporadic and variant CJD (Collinge, 1999; Ladogana et al., 2005; Palmer et al., 1991) . However, conflicting results have been reported about the relationship between polymorphism at codon 129 and the pathological and clinical features of AD (see Hooper and Turner, 2008; Poleggi et al., 2008 for reviews) although a systematic meta-analysis of AD genetic association studies revealed PRNP as a susceptible gene (see Bertram and Tanzi, 2008 for review) . APP processing is highly regulated. Disabled-1 (Dab1) is a cytosolic adaptor protein that is phosphorylated by members of the Src family of tyrosine kinases (SFK) in response to extracellular molecules during neural development (Howell et al., 1999b) . Several studies implicate Dab1 in APP processing (Hoe et al., 2006; Parisiadou and Efthimiopoulos, 2007; Trommsdorff et al., 1998 
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